March 28, 2025 09:48 AM EDTUpdated 12:40 PM

European regulator rejects Lilly's Alzheimer’s drug over potentially fatal side effects

Anna Brown

News Reporter

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER

ENDPOINTS CAREERS

COO / Head of Operations (Stealth Portfolio Company)‬ ‭

Autonomy Bio Inc.

San Francisco, CA 94107, USA

view job offer post your job now

TRENDING NOW

Trump asks 'very tough hombre' Dr. Oz to lead MFN talks

About 5% of CBER and CDER left after FDA staff cuts, analysis finds

US warns drugmakers against misrepresenting cost of imported products

Merus’ Phase 2 overall survival data reach ‘home run’ scenario — analyst

Geoffrey Porges exits Schrödinger with CFO swap; A new board seat for AstraZeneca's Pascal Soriot

sponsored

Does your supply chain hold up under pressure for high-risk temperature-critical shipments?